The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis

International Journal of Colorectal Disease

Volumn 22, Issue 9, 2007, Pages 999-1003

  Farnood, Alma ^a   Naderi, Nosratollah ^a   Moghaddam, Seyed Javad Mirhasani ^a   Noorinayer, Babak ^a   Firouzi, Farzad ^a   Aghazadeh, Rahim ^a   Daryani, Nasser Ebrahimi ^b   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C3435T polymorphism; Inflammatory bowel diseases; MDR1 gene; P glycoprotein; Ulcerative colitis

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 7; COLON MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMALL INTESTINE MUCOSA; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 7; COLITIS, ULCERATIVE; FEMALE; GENE FREQUENCY; GENES, MDR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRAN; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC;

EID: 34848900738     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0270-6     Document Type: Article

References (34)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429
2. Colombel JF, Tamboli C, Hugot JP (2004). Clinical genetics of inflammatory bowel diseases: Genetic epidemiology, genotype/phenotype correlations and pharmacogenetics. In: Sartor RB, Sandborn WJ (eds) Kirsner's Inflammatory bowel disease, 6th edn. Saunders, Philadelphia, PA, pp 263-279
3. Satsangi J, Parkes M, Louis E et al (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199-202
4. Brant S, Panhuysen C, Nicolae D et al (2003) MDR1 Ala893 Polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73:1282-1292
5. Farrell RJ, Murphy A, Long A et al (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118:279-288
6. Eichelbaum M, Fromm MF, Schwab M et al (2004) Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther Drug Monit 26(2):180-185
7. Sakaeda T, Nakamura T, Okumura K et al (2002) MDR1 Genotype-related pharmacokinetics and pharmacodynamics. Biol Pharm Bull 25(11):1391-1400
8. Wang BL, Zhai HY, Chen BY et al (2004) Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreat Dis Int 3(2):296-299
9. Marzolini C, Paus E, Buclin T et al (2004) Polymorphisms in human MDR1 (P -glycoprotein): Recent advances and clinical relevance. Clin Pharmacol Ther 75:13-33
10. Pawlik A, Wrzesniewska J, Fiedorowicz-Fabrycy I et al (2004) The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther 42(9):496-503
11. Ieiri I, Takane H, Otsubo K et al (2004) The MDR1(ABCB1) gene polymorphism and its clinical implications. Clin Pharmacokinet 43(9):553-576
12. Hitzl M, Schaeffeler E, Hocher B et al (2004) Variable expression of P -glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics 14(5):309-318
13. Potocnik U, Ferkolj I, Glavac D et al (2004) Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 5:530-539
14. Hoffmeyer S, Burk O, von Richter O et al (2000) Functional polymorphisms of the human multidrug resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97:3473-3478
15. Woodahl EL, Ho RJ (2004) The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function. Curr Drug Metab 5(1):11-19
16. Nakamura T (2003) MDR1 genotypes related to pharmacokinetics and MDR1 expression. Yakugaku Zasshi 123(9):773-779, [Abstract]
17. Schwab M, Schaeffeler E, Marx C et al (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124:26-33
18. Lawrance IC, Fiocchi C, Chakravarti S et al (2001) Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10:445-456
19. Yacyshyn B, Maksymowych W, Bowen Yacyshyn MB et al (1999) Differences in P glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis. Hum Immunol 60:677-687
20. Glas J, Torok H, Schieman U et al (2004) MDR1 Gene Polymorphism in Ulcerative Colitis. Gastroenterology 126:367-385
21. Zali M, Bahari A, Firouzi F et al (2006) Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal Dis 4:1-9 (Feb)
22. Sutherland LR, Xiao LF, Sartor RB (2004) Clinical trial design with an emphasis on indices to measure disease activity. In: Sartor RB, Sandborn WJ (eds) Kirsner's inflammatory bowel disease. Saunders, Philadelphia, PA, pp 453-468
23. Schaeffeler E, Eichelbaum M, Brinkmann U et al (2001) Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 358:383-384
24. Cascorbi I, Gerloff T, Johne A et al (2001) Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69(3):169-174
25. Ho GT, Nimmo ER, Tenesa A et al (2005) Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128(2):288-296
26. Croucher PJ, Mascheretti S, Foelsch UR et al (2003) Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology 125:1919-1920
27. Gazouli M, Zacharatos P, Gorgoulis V et al (2004) The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population. Gastroenterology 126(1):367-369
28. Jamroziak K, Balcerczak E, Mlynarski W et al (2002) Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population. Pol J Pharmacol 54(5):495-500
29. Balram C, Sharma A, Sivathasan C et al (2003) Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. Br J Clin Pharmacol 56(1):78-83
30. Cavaco I, Gil JP, Gil-Berglund E et al (2003) CYP3A4 and MDR1 alleles in a Portuguese population. Clin Chem Lab Med 41(10):1345-1350
31. Bernal ML, Sinues B, Fanlo A et al (2003) Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population. Ther Drug Monit 25(1):107-111
32. Siegsmund M, Brinkmann U, Schaffeler E et al (2002) Association of the P -glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13:1847-1854
33. Kim R, Leake B, Choo E et al (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70:189-199
34. Aghazadeh R, Zali MR, Bahari A et al (2005) Inflammatory bowel disease in Iran: A review of 457 cases. J Gastroenterol Hepatol 20(11):1691-1695 (Nov)